Theresa Wingrove
General Counsel bei IMMUNOGEN, INC.
Profil
Theresa G.
Wingrove is currently the Senior Vice President-Regulatory Affairs & Quality at ImmunoGen, Inc. She previously worked as the Senior Director-Clinical & Regulatory Affairs at MediSpectra, Inc. from 2000 to 2010.
She also held the position of Vice President-Clinical & Regulatory Affairs at Histogenics Corp.
from 2006 to 2011.
Dr. Wingrove has a doctorate degree from the University of Rochester and an undergraduate degree from Brown University.
Aktive Positionen von Theresa Wingrove
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNOGEN, INC. | General Counsel | 01.01.2011 |
Ehemalige bekannte Positionen von Theresa Wingrove
| Unternehmen | Position | Ende |
|---|---|---|
| OCUGEN, INC. | Chief Tech/Sci/R&D Officer | 01.01.2011 |
MediSpectra, Inc.
 MediSpectra, Inc. Miscellaneous Commercial ServicesCommercial Services MediSpectra, Inc. develops and manufactures medical devices. The firm develops proprietary optical detection technology for enhanced accuracy and real time results in the detection of cancer & other human tissue abnormalities. Its technology is based on multimodal optical interrogation of tissues with light. The company was founded in 1995 and is headquartered in Lexington, MA. | Chief Tech/Sci/R&D Officer | 26.03.2010 |
| PFIZER, INC. | Corporate Officer/Principal | - |
Ausbildung von Theresa Wingrove
| Rochester Christian University | Doctorate Degree |
| Brown University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| IMMUNOGEN, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
MediSpectra, Inc.
MediSpectra, Inc. Miscellaneous Commercial ServicesCommercial Services MediSpectra, Inc. develops and manufactures medical devices. The firm develops proprietary optical detection technology for enhanced accuracy and real time results in the detection of cancer & other human tissue abnormalities. Its technology is based on multimodal optical interrogation of tissues with light. The company was founded in 1995 and is headquartered in Lexington, MA. | Commercial Services |
Histogenics Corp.
 Histogenics Corp. BiotechnologyHealth Technology Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. | Health Technology |
